TScan Therapeutics (TSCAN) VP of Finance Resignation Announced

AI Summary

TScan Therapeutics (TSCAN) announced the resignation of its Vice President of Finance, though no specific date or reasons for the resignation were provided. This leadership change could potentially impact the company's financial reporting and investor confidence. Shareholder reactions may vary, depending on the perceived stability of the executive team. No further details about the future financial outlook or strategic direction of TScan Therapeutics were mentioned.